Renaissance Capital. (4/26/17). "News: Verona Pharma Prices IPO at $13.50".

	Region	United States (USA)
	Organisation	Verona Pharma plc (AIM: VRP + Nasdaq Global Market : VRNA)
	Group	Verona Pharma (Group)
	Organisation 2	Nasdaq
	Group	Nasdaq OMX (Group)
	Product	respiratory drug
	Product 2	investment banking
	Index term	Verona Pharma–SEVERAL: investment, 201704 US IPO $78m with 5.768m ADSs at $13.5/ADS at Nasdaq Global Market

Original document
accessed by [iito] on 2017-05-01

Record changed: 2023-06-05

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

More documents for Verona Pharma (Group)

[1] Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London....
[2] Verona Pharma plc. (4/27/17). "Press Release: Verona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market [Not for any jurisdiction where distribution would constitute a violation of relevant laws]". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]